Kidney International

Article	Citations
Journal Club	1276
Phosphate meeting cholesterol—consequences for cardiovascular disease in chronic kidney disease?	1099
Function follows form: the quest for the best prognostic imaging biomarker in ADPKD	647
Editorial Board	541
A pig kidney supporting human physiology	320
Subscription Information	310
In this issue	273
Editorial Board	217
Editorial Board	182
Challenges in the development of novel methodologies for measuring glomerular filtration rate	169
Gene editing: a near future for the treatment of genetic kidney diseases	159
In This Issue	156
Table of Contents	150
Subscription Information	145
Taking the A(llorecognition) train: connecting passenger T cells to DSA	134
Blood pressure adaptation in vertebrates: comparative biology	130
Misuse of the Cox proportional hazards model and alternative approaches in kidney outcome research	125
Kidney supportive care: every nephrologist’s business	123
Proximal-tubule molecular relay from early Protein diaphanous homolog 1 to late Rho-associated protein kinase 1 regulates kidney function in obesity-induced kidney damage	121
New advances in endocrine hypertension: from genes to biomarkers	121
Trans-ethnic genome-wide association study of blood metabolites in the Chronic Renal Insufficiency Cohort (CRIC) study	111
Enhancing kidney organoid maturity with inducible vascularization: another step forward for in vitro modeling	109
Including APOL1 alleles and ancestry adjustments improve a genome-wide polygenic CKD score	109
A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?	107
Identification of the gut microbial enzyme turning the urine yellow	106

A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease	103
Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today	102
Dysfunction of the circadian clock in the kidney tubule leads to enhanced kidney gluconeogenesis and exacerbated hyperglycemia in diabetes	102
Unexpected metabolic effects of sodium-glucose cotransporter 2 inhibitors	100
Glomerular-tubular crosstalk via cold shock Y-box binding protein-1 in the kidney	94
Kidney protective mechanisms of SGLT2 inhibitors: evidence for a hemodynamic effect	94
Improving frozen section evaluation of procurement donor kidney biopsies and reducing the discard rate: a promising role for artificial intelligence	93
Seeing through the density of dense deposit disease	92
The Case | Euglycemic ketoacidosis in a patient on continuous renal replacement therapy	87
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome	86
Should we consider calcimimetics as a therapeutic option for nephrotic syndrome?	85
Monoclonal immunoglobulin crystalline nephropathies	78
Thirsty encounters of the third kind	76
Endothelial but not systemic ferroptosis inhibition protects from antineutrophil cytoplasmic antibody–induced crescentic glomerulonephritis	75
Unlocking the full potential of human pluripotent stem cell–derived kidney organoids through bioengineering	75
Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients	75
Caloric restriction reduces the pro-inflammatory eicosanoid 20-hydroxyeicosatetraenoic acid to protect from acute kidney injury	74
Neutrophil gelatinase-associated lipocalin is elevated in children with acute kidney injury and sickle cell anemia, and predicts mortality	72
Multi-omics and imaging mass cytometry characterization of human kidneys to identify pathways and phenotypes associated with impaired kidney function	72
Women and kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference	72
Epigenetic alterations and memory: key players in the development/progression of chronic kidney disease promoted by acute kidney injury and diabetes	72
Ttc21b deficiency attenuates autosomal dominant polycystic kidney disease in a kidney tubular- and maturation-dependent manner	71
Editorial Board	69
The authors reply	69
Cinacalcet in focal segmental glomerular sclerosis: a case report	69
Editorial Board	68
Response to the commentary “Modeling pulse wave velocity trajectories—challenges, opportunities, and pitfalls”	68
Subscription Information	66
In This Issue	66
in this issue	65
Mutations in tumor suppressor genes Vhl and Rassf1a cause DNA damage, chromosomal instability and induce gene expression changes characteristic of clear cell renal cell carcinoma	64
Editorial Board	64
First do no harm: systemic glucocorticoids should not be used for the treatment of progressive IgA nephropathy	63
Unexpected cause of vemurafenib-induced nephrotoxicity: ferrochelatase	63
Mitochondrial ROS connects P2X7-mediated Ca2+ influx with IL-1α release by monocytes upon chronic tissue damage	63
AI applications in renal pathology	63
Immunoaging within the kidney via injury-associated tertiary lymphoid tissue	62
Urine: from waste to fertilizer	62
The Case | A patient with autosomal dominant polycystic kidney disease with an atypical kidney magnetic resonance image	62
A genomic deep field view of hypertension	61
The authors reply	61
Whole exome sequencing of large populations: identification of loss of function alleles and implications for inherited kidney diseases	61
Letter to the Editor	60
RORing toward immunoregulation in glomerulonephritis?	59
The T-cell environment: may the regulatory force be with you	59
Improving the management of chronic kidney disease in primary care by enhancing laboratory reports with additional information and follow-up procedures	58
The changing epidemiology of acute kidney injury syndromes in the face of emerging respiratory viral pandemic illnesses	58
Erdheim-Chester disease: hairy kidney and coated aorta	57
Kidney traits on repeat—the role of MUC1 VNTR	57
Corrigendum to “Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA–Associated Vasculitis.” Kidney International 2024;105(3):447–449	56

Erratum to Kudose S, Lipton M, Jain NG, D’Agati VD. “Valproic acid–associated proximal tubulopathy.” Kidney Int. 2022;101:653	55
The Case | A patient with skin rash, monoclonal gammopathy, and proteinuria	53
Subscription Information	53
journal club	52
Renal artery microaneurysms in antineutrophil cytoplasmic antibody–associated vasculitis	52
Acknowledgment of reviewers	52
Renal Pathology Society/International Kidney and Monoclonal Gammopathy Research Group consensus on pathologic definitions and terminology of monoclonal gammopathy–associated kidney lesions	52
The Case | Is this hemolytic uremic syndrome?	51
Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing/steroid-dependent nephrotic syndro	51
Tumor-induced osteomalacia	51
The transcription factor ATF4 mediates endoplasmic reticulum stress-related podocyte injury and slit diaphragm defects	50
Crystal-induced colitis	49
Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease	49
Pathological findings of immunotherapy-induced nephrotoxicity in a humanized immune system mouse model	48
The Case | Neonatal seizures and tubular dysfunction in childhood: joining the dots!	48
Proteinuria converts hepatic heparan sulfate to an effective proprotein convertase subtilisin kexin type 9 enzyme binding partner	48
Repression of peroxisome proliferation-activated receptor γ coactivator-1α by p53 after kidney injury promotes mitochondrial damage and maladaptive kidney repair	48
Hypoxia hits APOL1 in the kidney	48
The prevention and management of chronic kidney disease among patients with metabolic syndrome	48
Corrigendum to “Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rat	47
Kidney transplantation and hyperbaric oxygen treatment for calciphylaxis	47
Expanding the perspective: addressing additional limitations in cardiovascular risk assessment of immunosuppressive therapies	47
Identifying strategies for disseminating research to patients with chronic kidney disease and caregivers: a workshop report	47
Dynamically visualizing profibrotic maladaptive repair after acute kidney injury by fibroblast activation protein imaging	46
Machine learning does not outperform traditional statistical modelling for kidney allograft failure prediction	46
Complement activation and effector pathways in membranous nephropathy	45
Discrepancies between transcutaneous and estimated glomerular filtration rates in rats	44
Journal Club	44
Editorial Board	43
Expression of concern from the KI Editors: “Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria” [Kidney International, July 2021, Pages 146–154] and “APO	43
The relationship between imaging features of diffusion-weighted imaging and prognosis of chronic kidney disease	43
Advancing proteomics in nephrology: unraveling causal pathways and therapeutic targets	42
Title Page	42
National and international kidney failure registries: characteristics, commonalities, and contrasts	42
Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy	42
Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritis	42
Deciphering missense coding variants with AlphaMissense	42
High-dimensional mass cytometry identified circulating natural killer T-cell subsets associated with protection from cytomegalovirus infection in kidney transplant recipients	41
The authors reply	41
Table of Contents	41
Kidney biopsy in acute kidney injury: increase insight or preserve the status quo?	41
Female sex hormones inversely regulate acute kidney disease susceptibility throughout life	41
Editorial Board	40
Initiation of maintenance dialysis: back to the future	40
Table of Contents	40
in this issue	40
Estimating glomerular filtration rate from serum creatinine concentration in children with augmented renal clearance: all formulas are equivocal, but some are more equivocal than others	40
Subscription Information	40
Good and evil, more reasons to study UPR	40
A pragmatic, open-label, randomized controlled trial of Plasma-Lyte-148 versus standard intravenous fluids in children receiving kidney transplants (PLUTO)	39
Subscription Information	39
Integrating basic science with translational research: the 13th International Podocyte Conference 2021	39
Lineage tracing analysis defines erythropoietin-producing cells as a distinct subpopulation of resident fibroblasts with unique behaviors	39
Subscription Information	39
The Case | Acute kidney injury and a facial lesion	39
Dried blood spot testing versus standard i.v. sampling for GFR measurement with iohexol or 99mTc-DTPA	38
Do macrophages inhibit or promote atheroma plaque calcification and stability?	38
Modeling pulse wave velocity trajectories—challenges, opportunities, and pitfalls	37
Effective management of chyluria with retrograde thoracic duct catheterization and embolization	37
Risk stratification of metabolic disorder–associated kidney disease	37
Anti-nephrin autoantibodies: novel predictors of post-transplant recurrence of focal segmental glomerular sclerosis	37
Table of Contents	37
Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events	37
New-onset class III lupus nephritis with multi-organ involvement after COVID-19 vaccination	37
Acute kidney injury with gross hematuria and IgA nephropathy after COVID-19 vaccination	37
The nucleotide-sensing Toll-Like Receptor 9/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathy	37
Editorial Board	37
A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program	36
Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis	36
Contactin-1–associated membranous nephropathy: complete immunologic and clinical remission with rituximab	36
Endemic rise in cases of acute kidney injury in children in Indonesia and Gambia: what is the likely culprit and why?	36
Cardiovascular disease as a risk factor for frailty in dialysis patients	36
Loss of proximal tubular transcription factor Krüppel-like factor 15 exacerbates kidney injury through loss of fatty acid oxidation	35
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference	35
The lupus nephritis management renaissance	35
Insulin-like growth factor binding protein 7 promotes acute kidney injury by alleviating poly ADP ribose polymerase 1 degradation	35
Critical Role of histone deacetylase 3 in the regulation of kidney inflammation and fibrosis	35
Enhancer and super-enhancer landscape in polycystic kidney disease	35
The authors reply:	35
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns	35

Apixaban for stroke prevention in hemodialysis patients with nonvalvular atrial fibrillation	35
Findings from 4C-T Study demonstrate an increased cardiovascular burden in girls with end stage kidney disease and kidney transplantation	35
Role of proteinuria in the anemia of chronic kidney disease	35
ER stress and slit diaphragms: is there a connection?	34
The authors reply	34
Subscription Information	34
Series introduction: drug repurposing for kidney diseases	34
Subscription Information	34
Scaffold polarity proteins Par3A and Par3B share redundant functions while Par3B acts independent of atypical protein kinase C/Par6 in podocytes to maintain the kidney filtration barrier	34
In this issue	34
Editorial Board	33
Protective mechanisms harnessing against injurious heme and preventing kidney damage in STEC-HUS: toward new therapies?	33
Uremia-associated fibrinous pericarditis	32
Valproic acid–associated proximal tubulopathy	32
Supportive therapy for cast nephropathy	32
journal club	32
A novel model of nephrotic syndrome results from a point mutation in Lama5 and is modified by genetic background	32
Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis	31
in this issue	31
The author replies:	31
Has APOL1 kidney disease treatment been hiding in plain sight?	31
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease	31
Antioxidant nanozymes for prevention of diseased kidney from failure	31
Acquired cutis laxa from heavy chain deposition disease	31
Subscription Information	31
In this Issue	31
Intradialytic exercise improves left ventricular mass in hemodialysis patients	31
Is bone histomorphometry required for assessment of renal osteodystrophy in clinical practice?	31
Receptor activator of NF-κB mediates podocyte injury in diabetic nephropathy	30
The Case | Dark dialysate after colonoscopy	30
The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation	30
Calpastatin prevents Angiotensin II–mediated podocyte injury through maintenance of autophagy	30
Differing sensitivities to angiotensin converting enzyme inhibition of kidney disease mediated by APOL1 high-risk variants G1 and G2	30
A polygenic score for reduced kidney function and adverse outcomes in a cohort with chronic kidney disease	30
The authors reply:	29
Asymptomatic migration of a peritoneal dialysis catheter	29
Using prediction models to improve care and communicate risk: updated modeling for children with IgA nephropathy	29
How cyclosporine reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do not	29
An introduction to realist evaluation and synthesis for kidney research	29
The authors reply	29
Outcome of diacylglycerol kinase epsilon–mediated hemolytic uremic syndrome in an infant	29
Table of Contents	29
Recommendations from the EXTRIP workgroup on extracorporeal treatment for baclofen poisoning	28
Kidney toxicity of phosphate: is that crystal clear yet?	28
Mendelian randomization for nephrologists	28
The Case | An unusual cause of proteinuria in a kidney transplant recipient	28
A national registry study evaluated the landscape of kidney transplantation among presumed unauthorized immigrants in the United States	27
in this issue	27
Progress, challenges, and pragmatic concessions in predicting relative risk of kidney survival in ARPKD	27
Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis	27
Kidney targeting of formoterol containing polymeric nanoparticles improves recovery from ischemia reperfusion-induced acute kidney injury in mice	27
The authors reply	26
Glomerular filtration rate estimation in transgender and gender-diverse adults using gender-affirming hormone therapy: an exploratory cross-sectional study	26
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary	26
Myeloid-derived growth factor deficiency exacerbates mitotic catastrophe of podocytes in glomerular disease	26
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children	26
Anti-nephrin antibodies guide living donor kidney transplantation in a pediatric patient with primary focal segmental glomerular sclerosis.	26
In remembrance of Gary Striker, MD (1934–2024)	26
The Case | A 38-year-old man with hydronephrosis	26
A genetically inducible endothelial niche enables vascularization of human kidney organoids with multilineage maturation and emergence of renin expressing cells	26
Are your kidneys Ok? Detect early to protect kidney health	26
Conservative kidney management and kidney supportive care: core components of integrated care for people with kidney failure	26
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis	26
Subscription Information	25
Should vaccination against COVID-19 be mandated in patients on the transplant waiting list?	25
In memoriam: George L. Bakris, MD, 1952–2024	25
Editorial Board	25
Subscription Information	25
Journal club	25
Autogenous brachial-axillary translocated superficial femoral vein hemodialysis access with a prosthetic outflow bypass	25
Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2	25
Cilastatin, a new therapeutic promise for acute kidney injury	24
Advanced optical imaging reveals preferred spatial orientation of podocyte processes along the axis of glomerular capillaries	24
in this issue	24
The CCR6/CCL20 axis expands RORγt+ Tregs to protect from glomerulonephritis	24
Preventing MMP23-mediated cleavage of podocyte RARRES1: a novel strategy to halt chronic kidney disease progression?	24
in this issue	24
Title Page	24
Targeting angiopoietin-2 as a novel treatment option for kidney fibrosis	24
Table of Contents	24
Corrigendum to Cai J, Liu Z, Huang X, et al. The deacetylase sirtuin 6 protects against kidney fibrosis by epigenetically blocking β-catenin target gene expression Kidney Int. 2020;97:106–118	24
Hemolysis is associated with altered heparan sulfate of the endothelial glycocalyx and with local complement activation in thrombotic microangiopathies	23
Epithelial proliferation and cell cycle dysregulation in kidney injury and disease	23
Avoiding arrythmias by personalizing the dialysate concentration: a case for precision medicine in patients on dialysis	23
Unique problems for the design of the first trials of transplanting porcine kidneys into humans	23
Melanocortin 5 receptor signaling protects against podocyte injury in proteinuric glomerulopathies	23
Doxorubicin-associated red-colored dialysate	23
Multi-stain deep learning prediction model of treatment response in lupus nephritis based on renal histopathology	23
A reliable clinical test for detection of membranous nephropathy antigens using laser microdissection and mass spectrometry	23
Suppression of aldehyde dehydrogenase 2 in kidney proximal tubules contributes to kidney fibrosis through Transforming Growth Factor-β signaling	23
Windswept deformity of lower limbs in a patient with end-stage renal disease and rickets	23
E-prostanoid 3 receptor deficiency on myeloid cells protects against ischemic acute kidney injury via breaking the auto-amplification loop of necroinflammation	22
The genetic background significantly impacts the severity of kidney cystic disease in the Pkd1RC/RC mouse model of autosomal dominant polycystic kidney disease	22
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with	22
Type I interferon–related kidney disorders	22